Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Rockefeller University researchers have uncovered how Langerhans immune cells act as a biological "rheostat," fine-tuning skin stem cell activity to maintain a healthy skin barrier. Published in Science, the study shows these cells sense microbes on the skin surface and use a chemical signal (PGE2) to regulate stem cell growth and differentiation. Without this system, the skin barrier weakens and becomes vulnerable to bacterial overgrowth.
Researchers at Rockefeller University have discovered a previously unknown regulatory circuit in the skin — and it's more elegant than anyone expected. Published in Science, the study reveals that Langerhans cells (LCs), a type of immune cell embedded in the skin, act as a biological "rheostat," continuously sensing microbial signals at the skin surface and relaying instructions to epidermal stem cells to either proliferate or differentiate.
The key mechanism: Langerhans cells express a gene called Ptgs1, which encodes the enzyme COX-1. This enzyme drives robust production of a signaling molecule called PGE2, which binds to a specific receptor (EP4) on epidermal stem cells — the only prostaglandin receptor those stem cells have. This PGE2 signal acts as a brake on stem cell proliferation, ensuring cells mature properly before reaching the skin surface.
When this circuit breaks down, the consequences are significant — immature skin cells reach the surface before fully developing, the skin barrier weakens structurally, native bacteria overgrow, and antimicrobial peptide production drops.
Key Takeaways:
Why it matters: This discovery reframes how we understand skin immunity and barrier maintenance, opening new avenues for treating conditions where the skin barrier is compromised, such as atopic dermatitis and chronic skin infections.
